Inhibition of HER2/neu (erbB-2) and Mitogen-activated Protein Kinases Enhances Tamoxifen Action against HER2-overexpressing, Tamoxifen-resistant Breast Cancer Cells1
Cancer Res (2000) 60 (20): 5887–5894.
Currently there are no citedby results. Try again later.
